CA Stock MarketDetailed Quotes
ENBI Entheon Biomedical Corp
- 0.140
- 0.0000.00%
15min DelayMarket Closed Nov 27 10:00 ET
1.24MMarket Cap-3500P/E (TTM)
0.000High0.000Low0Volume0.000Open0.140Pre Close0.00Turnover0.25052wk High0.00%Turnover Ratio8.86MShares0.05052wk Low-0.04EPS TTM1.20MFloat Cap13.500Historical HighLossP/E (Static)8.57MShs Float0.050Historical Low-0.05EPS LYR0.00%Amplitude--Dividend TTM5.38P/B1Lot Size--Div YieldTTM
Entheon Biomedical Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 52.27%-70.54K | -515.05%-98.28K | 49.95%-94.71K | 75.45%-359.93K | 27.01%-46.57K | -143.90%-147.78K | 103.19%23.68K | 81.01%-189.25K | 71.60%-1.47M | 92.30%-63.81K |
| Net income from continuing operations | 50.17%-64.7K | ---94.56K | 21.69%-74.86K | 85.45%-300K | 69.43%-74.56K | -119.23%-129.85K | --0 | 93.81%-95.59K | 74.23%-2.06M | 75.16%-243.9K |
| Operating gains losses | ---- | ---- | ---- | -100.83%-4.4K | ---- | ---- | ---- | ---- | 262.76%528.49K | 5,180.43%122.77K |
| Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -45.41%2.1K | 100.24%1.09K |
| Unrealized gains and losses of investment securities | ---- | --0 | --0 | --0 | ---- | ---- | 101.42%5.45K | -168.46%-13.81K | -486.14%-457.44K | 49.01%-142.16K |
| Remuneration paid in stock | --0 | --0 | --0 | -98.62%1.18K | 100.01%21 | 30.77%-1.18K | -99.05%840 | -99.12%1.5K | -96.66%85.31K | -119.29%-170.74K |
| Change In working capital | 76.77%-5.84K | -121.40%-3.72K | 75.59%-19.85K | -112.98%-56.71K | -91.23%32.37K | 93.24%-25.12K | -79.09%17.4K | -122.82%-81.35K | -10.17%436.86K | 10,756.18%369.13K |
| -Change in receivables | 99.00%-38 | -96.80%2.43K | 99.47%-217 | 596.75%35.89K | -61.51%4.56K | 75.49%-3.79K | 1,198.87%75.92K | -1,331.23%-40.8K | -108.99%-7.22K | -28.08%11.85K |
| -Change in prepaid assets | -42.65%15.56K | 4.45%3.31K | 140.07%14.68K | -102.16%-23.27K | -106.62%-16.95K | -91.41%27.14K | -98.79%3.17K | -115.05%-36.63K | 173.48%1.08M | 142.97%255.94K |
| -Change in payables and accrued expense | 55.93%-21.36K | 84.67%-9.46K | -776.08%-34.32K | 89.06%-69.32K | -55.84%44.76K | 92.79%-48.47K | 64.24%-61.7K | -103.57%-3.92K | -5,453.64%-633.82K | -82.37%101.35K |
| Cash from discontinued investing activities | 0 | -7.84%-488.44K | -34.9K | |||||||
| Operating cash flow | 52.27%-70.54K | -515.05%-98.28K | 49.95%-94.71K | 81.59%-359.93K | 52.82%-46.57K | -184.06%-147.78K | 102.85%23.68K | 84.23%-189.25K | 65.19%-1.95M | 92.30%-98.7K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -95.99%24.4K | -98.21%9.4K | 258.30%608.87K | 244.95%525.74K | ||||||
| Net investment purchase and sale | ---- | ---- | ---- | -99.31%4.4K | ---- | ---- | ---- | ---- | 264.79%633.87K | 2,508.26%550.74K |
| Net other investing changes | ---- | ---- | ---- | 180.00%20K | --5K | ---- | ---- | ---- | ---25K | ---- |
| Cash from discontinued investing activities | 0 | -108.13%-23.23K | 4.75K | |||||||
| Investing cash flow | ---- | ---- | ---- | -95.83%24.4K | -98.23%9.4K | ---- | ---- | ---- | 692.36%585.64K | 789.58%530.49K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | ||||||||
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -39.07%299.14K | -49.09%249.92K | -49.33%344.63K | -66.81%680.17K | 53.72%381.81K | 4.99%490.91K | -40.23%490.91K | -66.81%680.17K | -26.48%2.05M | -92.66%248.39K |
| Current changes in cash | 35.35%-70.54K | --49.22K | 49.95%-94.71K | 75.49%-335.53K | -108.61%-37.18K | 50.23%-109.1K | --0 | 84.59%-189.25K | -85.53%-1.37M | 132.37%431.78K |
| End cash Position | -40.13%228.6K | -39.07%299.14K | -49.09%249.92K | -49.33%344.63K | -49.33%344.63K | 53.72%381.81K | 4.99%490.91K | -40.23%490.91K | -66.81%680.17K | -66.81%680.17K |
| Free cash from | 52.27%-70.54K | -515.05%-98.28K | 49.95%-94.71K | 81.59%-359.93K | 52.82%-46.57K | -184.06%-147.78K | 102.85%23.68K | 84.23%-189.25K | 65.19%-1.95M | 91.94%-98.7K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data